Ocular Surface Diseases, Disorders, and Dysfunctions®: Volume 5, Number 1

1.25 CME
1.00 COPE
75 MINS
$0 FEE
SAVE
Ocular Surface Disease OG Image Size

Overview

Provider Statement

This continuing medical education activity is provided by Vindico Medical Education

This continuing education activity is provided by Purdue U


Support Statement

This activity is supported by an educational grant from Shire.


Target Audience

The intended audience for this activity is ophthalmologists, optometrists, and other health care professionals involved in the treatment of patients with ocular surface disorders.


Learning Objectives

Upon successful completion of the publication series, participants should be better able to:

  • Evaluate new methods and modalities that assist in the diagnosis of ocular surface and dry eye disease.
  • Investigate the use of dry eye therapies in specific patient populations to better understand the attributes and limitations of monotherapy and combination therapy in these patients.
  • Assess the management of dry eye disease and ocular surface disorders both preoperatively and postoperatively to improve surgical outcomes.

Chief Medical Editor

Terry Kim, MD
Professor of Ophthalmology
Duke University School of Medicine
Chief, Cornea and External Disease Division
Director, Refractive Surgery Service
Duke University Eye Center
Durham, NC


Associate Medical Editor

Paul M. Karpecki, OD, FAAO
Director, Cornea Services 
Kentucky Eye Institute
Lexington, KY


Editorial Board

Brandon D. Ayres, MD
Cornea Service
Co-Director of Cornea Fellowship
Wills Eye Hospital
Philadelphia, PA

Marjan Farid, MD
Associate Professor of Ophthalmology
Director of Cornea, Cataract, and Refractive Surgery
Gavin Herbert Eye Institute
University of California, Irvine
Irvine, CA

Preeya K. Gupta, MD*
Associate Professor of Ophthalmology
Duke University School of Medicine
Cornea, Cataract, and Refractive Surgery
Clinical Director, Duke Eye Center
Durham, NC

Christopher E. Starr, MD, FACS*
Associate Professor of Ophthalmology
Director, Refractive Surgery
Director, Cornea Fellowship
Director, Ophthalmic Education
Weill Cornell Medicine
New York Presbyterian Hospital
New York, NY

*Faculty Contributor also for this issue.


Guest Contributors

Stephanie M. Cox, OD
Postdoctoral Research Fellow
Tufts Medical Center
Boston, MA

Alice T. Epitropoulos, MD, FACS
Ophthalmic Surgeons and Consultants of Ohio
The Eye Center of Columbus
Clinical Assistant Professor
The Ohio State University Medical Center
Columbus, OH

Pedram Hamrah, MD, FACS
Professor of Ophthalmology
Tufts University School of Medicine
Director, Center for Translational Ocular Immunology
Director, Clinical Research
Tufts Medical Center
Boston, MA

M. Cuneyt Ozmen, MD, FICO
Postdoctoral Clinical Research Fellow
Tufts Medical Center
Tufts University School of Medicine
Boston, MA
Associate Professor of Ophthalmology
Gazi University School of Medicine
Ankara, Turkey

Eric Rosenberg, DO, MSE
Cornea and Refractive Surgery Fellow
Weill Cornell Medicine
New York Presbyterian Hospital
New York, NY

John D. Sheppard, MD, MMSc, FACS
Professor of Ophthalmology, Microbiology & Molecular Biology
Clinical Director, Thomas R. Lee Center for Ocular Pharmacology
Director, Eastern Virginia Medical School
President, Virginia Eye Consultants
Norfolk, VA


Reviewers

Ashay Bhatwadekar, MPharm, PhD
Ronald A. Codario, MD, EMBA, FACP, FNLA, RPVI, CHCP


Medical Writer

Valerie Zimmerman, PhD


Accreditation

Purdue University is approved by the Council on Optometric Practitioner Education (COPE) as an administrator/provider of continuing education (CE).

Vindico Medical Education is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.


Credit Designation

This enduring material is COPE-accredited for 1.0 continuing education credits and is approved for one (1) year from the date of original release, July 1, 2019 to July 1, 2020.

COPE ID #: 63164-AS
COPE Event #: 117708

Please consult your state’s Board of Optometry to determine if the CE credit may apply toward your CE requirement for license renewal.

Vindico Medical Education designates this enduring material for a maximum of 1.25 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.


How to Participate in This Activity and Obtain CE/CME Credit

To participate in this CE/CME activity, you must read the objectives, answer the pretest questions, read the articles, and complete the posttest and evaluation. Provide only one (1) correct answer for each question. A satisfactory score is defined as answering 70% of the posttest questions correctly. If a satisfactory score on the posttest is achieved, Purdue University will issue a CE Certificate or Vindico Medical Education will issue an AMA PRA Category (1) Credit(s) certificate.


Disclosures

In accordance with the Accreditation Council for Continuing Medical Education’s Standards for Commercial Support, all CME providers are required to disclose to the activity audience the relevant financial relationships of the planners, reviewers, teachers, and authors involved in the development of CME content. An individual has a relevant financial relationship if he or she has a financial relationship in any amount occurring in the past 12 months with a commercial interest whose products or services are discussed in the CME activity content over which the individual has control.


Editorial Board and Faculty report the following relationship(s)

Brandon D. Ayres, MD
Consulting Fee: Alcon, Allergan, Bausch + Lomb, Gore, MicroSurgical Technology, Omeros, Shire, Sight Sciences
Speakers Bureau: Alcon, Allergan, Shire

Stephanie M. Cox, OD
No relevant financial relationships to disclose.

Alice T. Epitropoulos, MD, FACS
Intellectual Property/Patent: EpiGlare Tester
Consulting Fee: Abbott Medical Optics, Alcon, Allergan, Bausch + Lomb, Bio-Tissue, Eyevance, Omeros, Physician Recommended Nutriceuticals, Shire, Sight Sciences, Sun, TearLab, TearScience, TissueTech, Zeiss
Speakers Bureau: Abbott Medical Optics, Alcon, Allergan, Bausch + Lomb, Bio-Tissue, Eyevance, Omeros, Physician Recommended Nutriceuticals, Shire, Sight Sciences, Sun, TearLab, TearScience, TissueTech, Zeiss
Contracted Research: InSite Vision, MDbackline, TearSolutions
Ownership Interest: Eyevance
Grant/Research Support: Bausch + Lomb, Kala, Ocular Therapeutix, Physician Recommended Nutriceuticals, TearLab

Marjan Farid, MD
Consulting Fee: Allergan, CorneaGen, Dompe, EyePoint, Eyevance, Johnson & Johnson Vision, Kala, Takeda

Preeya K. Gupta, MD
Consulting Fee: Alcon, Allergan, Aurea, Bausch + Lomb, Johnson & Johnson Vision, Kala, NovaBay, Novartis, Ocular Science, Omeros, Shire, TearLab, TearScience, Zeiss

Pedram Hamrah, MD, FACS
Consulting Fee: Bio-Tissue, Dompe, Noveome
Contracted Research: Bio-Tissue, Dompe

Paul M. Karpecki, OD, FAAO
Consulting Fee: Aerie, Alcon, Allergan, Akorn, Anthem, Avellino, Bausch + Lomb, Bio-Tissue, BlephEx, Bruder Healthcare, Cambium, eyeBrain, EyeGate, EyePoint, Eyevance, Focus Labs, Icare, Imprimis, Ivantis, Jobson Healthcare, Johnson & Johnson, Konan, Lentechs, Maculogix, Nevakar, Notal Vision, Novaliq, Novartis, Oasis Medical, Ocular Sciences, Oculus, OcuMedic, OCuSOFT, Oyster Point, PECAA, Quark, Refocus Group, Reichert, Rendia, RxSight, ScienceBased Health, Sentiss, Shire, Sight Sciences, Sun, TLC, Toncon, Vmax, Zeiss
Contracted Research: Novartis, Shire, Sight Sciences
Ownership Interest: Bruder Healthcare, Ophthalmic Resources, Optometric Medical Solutions, Silk Technologies, Tarsus Medical, TearLab

Terry Kim, MD
Consulting Fee: Aerie, Alcon/Novartis, Allergan/Actavis, Avedro, Avellino Labs, Bausch + Lomb/Valeant, BlephEx, CoDa/Ocunexus Therapeutics, Kala, NovaBay, Ocular Therapeutix, Omeros, PowerVision, Presbyopia Therapies, Shire, Simple Contacts, TearLab, Zeiss
Ownership Interest: Avellino Labs, CorneaGen, Kala, NovaBay, Ocular Therapeutix, Omeros, Simple Contacts

M. Cuneyt Ozmen, MD, FICO
No relevant financial relationships to disclose.

Eric Rosenberg, DO, MSE
No relevant financial relationships to disclose.

John D. Sheppard, MD, MMSc, FACS
Consulting Fee: AbbVie, Allergan, Bausch + Lomb, Bio-Tissue, Clearside, Eleven, Hovione, Johnson & Johnson/TearScience, Kowa, MedEdicus, NovaBay, Noveome, Ocular Therapeutix, ScienceBased Health, Sun, TearLab
Speakers Bureau: AbbVie, Alcon/Novartis, Allergan, Avedro, Bausch + Lomb, Bio-Tissue, Eleven, EyeGate, Inspire/Merck, Mallinckrodt, MedEdicus, Nicox, Omeros, Pentavision, Pfizer, Santen, TearLab, Topcon
Ownership Interest: 1-800-DOCTORS, Alphaeon, BioLayer, EyeGate, EyeRx, NovaBay, OccuHub, OcuCure, RPS, Stemnion, TearLab

Christopher E. Starr, MD, FACS
Consulting Fee: Alcon/Novartis, Allergan, BlephEx, Bruder, Dompe, EyePoint, Evevance, Kala, Quidel, Shire, Sun, TearLab
Contracted Research: Shire
Ownership Interest: TearLab


Reviewers report the following relationship(s)

Ashay Bhatwadekar, MPharm, PhD
No relevant financial relationships to disclose.

Ronald A. Codario, MD, EMBA, FACP, FNLA, RPVI, CHCP
No relevant financial relationships to disclose.


Medical Writer reports the following relationship(s)

Valerie Zimmerman, PhD
No relevant financial relationships to disclose.


Purdue University and Vindico Medical Education staff report the following relationship(s)

No relevant financial relationships to disclose.

Signed disclosures are on file at Purdue University and Vindico Medical Education, Office of Medical Affairs and Compliance.


Unlabeled and Investigational Usage

The audience is advised that this continuing medical education activity may contain references to unlabeled uses of US Food and Drug Administration (FDA)-approved products or to products not approved by the FDA for use in the United States. The faculty members have been made aware of their obligation to disclose such usage. All activity participants will be informed if any speakers/authors intend to discuss either non–FDA-approved or investigational use of products/devices.


Copyright Statement

Created and published by Vindico Medical Education, 6900 Grove Road, Building 100, Thorofare, NJ 08086-9447. Telephone: 856-994-9400; Fax: 856-384-6680. Printed in the USA. Copyright © 2019 Vindico Medical Education. All rights reserved. No part of this publication may be reproduced without written permission from the publisher. The material presented at or in any of Purdue University and Vindico Medical Education continuing education activities does not necessarily reflect the views and opinions of Purdue University and Vindico Medical Education. Neither Purdue University and Vindico Medical Education nor the faculty endorse or recommend any techniques, commercial products, or manufacturers. The faculty/authors may discuss the use of materials and/or products that have not yet been approved by the US Food and Drug Administration. All readers and continuing education participants should verify all information before treating patients or utilizing any product.


CME/COPE Questions?

Contact us at:
Purdue University: cmemda@purdue.edu or 765-496-1306
Vindico Medical Education: cme@vindicocme.com or 856-994-9400, ext. 504